Japanese Dose-Response Study of Rimonabant in Obese Patients

Summary

The primary objective is to verify the dose-response relationship of rimonabant on body weight change. The secondary objectives are to compare the effect of 3 doses of SR141716 to placebo, on body weight loss and on secondary criteria associated with comorbidities, and to evaluate the safety and the pharmacokinetics of SR141716.

Timeline

Start

2004-10

Primary completion

2006-04

Completion

2006-04

Drugs

Indications